Skip to content

Effect of herbal extracts on fatty liver disease

Comparing the effect of combined extract of Fumaria parviflora, Salix aegyptiaca, Taraxacum officinale ,Coriandrum sativum L versus Vit E on liver enzymes level in patients with fatty liver disease

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017082935963N1
Enrollment
82
Registered
2017-10-30
Start date
2017-04-21
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

fatty liver disease. Fatty (change of) liver, not elsewhere classified

Interventions

Intervention group 1: Comparison of effectiveness of combined extract of Fumaria parviflora, Salix aegyptiaca, Taraxacum officinale ,Coriandrum sativum L. 100 ml BID
Intervention group 2: vit E 400 mg daily
Intervention 1: Intervention group 1: Comparison of effectiveness of combined extract of Fumaria parviflora, Salix aegyptiaca, Taraxacum officinale ,Coriandrum sativum L. 100 ml BID. Intervention 2:
Treatment - Drugs

Sponsors

Vice Chancellor for research of Sabzevar University of Medicine Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: AST, ALT more than 1.5 equivalents of normal range plus sonographic confirmation; from 20 to 60 years old Exclusion criteria : alcoholic drinks user( now or in past); being athlete; hospitalized; Acute or chronic disease before or at the time of intervention that can affects liver function tests; Taking drugs before or at the time of intervention that could affects liver function tests; Pregnancy or breastfeeding; Younger than 20 or older than 60 years old

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Aminotransferases. Timepoint: 1-3 days before intervention and 40 days after intervention. Method of measurement: U/L.

Secondary

MeasureTime frame
Cholestrol. Timepoint: 1-3 days before intervention and 40 days after the intervention. Method of measurement: Mg/dl.;Triglyceride. Timepoint: 1-3 days before intervention and 40 days after the intervention. Method of measurement: Mg/dl.;Fasting blood sugar. Timepoint: 1-3 days before intervention and 40 days after the intervention. Method of measurement: Mg/dl.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan sahbayi Ejlali

Sabzevar University of Medical Sciences

e24267s@gmail.com+98 51 4401 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026